SCHEMBL7004159

SCHEMBL7004159

CCCOc1ccccc1-c1nc2c(-c3ccccn3)n[nH]c2c(=O)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.57
KDM4E B2RXH2 2/20 0.57
ALDH1A1 P00352 2/20 0.57
KMT2A Q03164 2/20 0.57
PDE4A P27815 2/20 0.57
PDE4B Q07343 2/20 0.57
PDE4C Q08493 2/20 0.57
PDE4D Q08499 2/20 0.57
MEN1 O00255 1/20 0.57
PDE2A O00408 1/20 0.57
PDE6D O43924 1/20 0.57
USP2 O75604 1/20 0.57
PDE9A O76083 1/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.57
MAPT P10636 1/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
PDE6A P16499 1/20 0.57
PDE6G P18545 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001635 0.84 PDE5A (0.56) PDE5AKDM4EALDH1A1KMT2APDE4A
SCHEMBL6332612 0.83 PDE5A (0.61) PDE5AKDM4EALDH1A1KMT2APDE4A
SCHEMBL6202064 0.82 PDE5A (0.63) PDE5AKDM4EALDH1A1KMT2APDE4A
SCHEMBL7000335 0.80 PDE5A (0.66) PDE5APDE6CPDE11A
Potassium Ion SCHEMBL7465463 0.77 PDE5A (0.57) PDE5AKDM4EALDH1A1KMT2APDE4A
SCHEMBL7001931 0.76 PDE5A (0.54) PDE5AKDM4EALDH1A1KMT2APDE4A
SCHEMBL7408452 0.76 PDE5A (0.67) PDE5AKDM4EALDH1A1KMT2APDE4A
SCHEMBL6332419 0.75 PDE5A (0.62) PDE5AKDM4EALDH1A1KMT2AMEN1
SCHEMBL7722659 0.74 PDE5A (0.67) PDE5AKDM4EALDH1A1KMT2APDE4A
SCHEMBL1028 0.74 PDE5A (0.68) PDE5AKDM4EALDH1A1KMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123296-B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LTD (GB) 2003-09-17 EP disclosed
US-6333330-B1 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-12-25 US disclosed
EP-1123296-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2001-08-16 EP disclosed
WO-2000024745-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 2000-05-04 WO disclosed